Allosteric equilibria in the binding of fibrinogen to platelets.

AUTOR(ES)

De Cristofaro, R

RESUMO

The binding of fibrinogen to platelets occurs according to the law of mass action. The platelet receptor binds reversibly a single fibrinogen molecule and undergoes a conformational transition between two allosteric states, T and R, that differ in their affinity for fibrinogen. The equilibrium between the two forms is shifted by ADP toward the R (high-affinity) state, thus promoting the aggregation process. This model opens the way to consideration of allosteric modulation of the binding of fibrinogen to its platelet receptor.

Documentos Relacionados

• The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
• ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
• Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
• Binding of the products of prothrombin activation to human platelets.
• Binding of collagen alpha1 chains to human platelets.